Larimar Therapeutics (LRMR) Retained Earnings: 2013-2020
Historic Retained Earnings for Larimar Therapeutics (LRMR) over the last 7 years, with Sep 2020 value amounting to -$51.4 million.
- Larimar Therapeutics' Retained Earnings rose 86.79% to -$51.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$51.4 million, marking a year-over-year increase of 86.79%. This contributed to the annual value of -$23.1 million for FY2019, which is 93.41% up from last year.
- Latest data reveals that Larimar Therapeutics reported Retained Earnings of -$51.4 million as of Q3 2020, which was down 24.98% from -$41.1 million recorded in Q2 2020.
- Over the past 5 years, Larimar Therapeutics' Retained Earnings peaked at -$23.1 million during Q4 2019, and registered a low of -$399.9 million during Q1 2020.
- Moreover, its 3-year median value for Retained Earnings was -$336.4 million (2018), whereas its average is -$269.0 million.
- Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 66.09% in 2016, then spiked by 93.41% in 2019.
- Over the past 5 years, Larimar Therapeutics' Retained Earnings (Quarterly) stood at -$237.5 million in 2016, then declined by 21.90% to -$289.6 million in 2017, then fell by 21.19% to -$350.9 million in 2018, then soared by 93.41% to -$23.1 million in 2019, then spiked by 86.79% to -$51.4 million in 2020.
- Its Retained Earnings was -$51.4 million in Q3 2020, compared to -$41.1 million in Q2 2020 and -$399.9 million in Q1 2020.